Protara Therapeutics Inc. (NASDAQ: TARA)
$2.40
+0.0200 ( +0.84% ) 227.6K
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops, and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).
Market Data
Open
$2.40
Previous close
$2.38
Volume
227.6K
Market cap
$49.42M
Day range
$2.28 - $2.61
52 week range
$1.04 - $5.24
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jan 12, 2024 |
4 | Insider transactions | 1 | Jan 12, 2024 |
4 | Insider transactions | 1 | Jan 12, 2024 |
4 | Insider transactions | 1 | Jan 05, 2024 |
4 | Insider transactions | 1 | Jan 05, 2024 |
4 | Insider transactions | 1 | Jan 05, 2024 |
8-k | 8K-related | 14 | Nov 03, 2023 |
10-q | Quarterly Reports | 61 | Nov 03, 2023 |
10-q | Quarterly Reports | 62 | Aug 03, 2023 |
8-k | 8K-related | 14 | Aug 03, 2023 |